Anbipine (688393.SH): No technology related to human stem cells yet

Gelonghui, May 10丨An Biping (688393.SH) said on the interactive platform that the company's main business includes cancer screening and accurate diagnosis, mainly for hospital pathology departments, and has not yet involved human stem cell-related technology.

Gelonghui FinanceMay 10 03:51 ET

Chinese Drug Regulator Grants Certificates to Two LBP Medicine Science & Technology Products

Guangzhou LBP Medicine Science & Technology (SHA:688393) obtained a medical device registration certificate from China's National Medical Products Administration for two products, according to the com

MT NewswiresMay 8 03:12 ET

Anbiping (688393.SH) obtained medical device registration certificate for 2 in vitro diagnostic reagents

Anbiping (688393.SH) announced that the company recently received “Medical Devices...” issued by the State Drug Administration

Zhitong FinanceMay 7 04:10 ET

Anbiping (688393.SH)'s net profit of 7.99 million yuan in the first quarter increased 2.17% year over year

Gelonghui, April 29丨An Biping (688393.SH) announced that in the first quarter of 2024, the company's revenue was 101 million yuan, up 11.82% year on year; net profit attributable to shareholders of listed companies was 7.99 million yuan, up 2.17% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 4.8 million yuan, up 78.59% year on year.

Gelonghui FinanceApr 29 03:58 ET

Guangzhou LBP Medicine Science & Technology's (SHSE:688393) Shareholders Have More To Worry About Than Only Soft Earnings

The market rallied behind Guangzhou LBP Medicine Science & Technology Co., Ltd.'s (SHSE:688393) stock, leading do a rise in the share price after its recent weak earnings report. We think that shareh

Simply Wall StApr 29 02:28 ET

LBP Medicine Scraps Convertible Bonds Issuance Plans

Guangzhou LBP Medicine Science & Technology (SHA:688393) withdrew plans to issue convertible bonds, the company said in its filing on the Shanghai Stock Exchange. The Chinese diagnostic product manufa

MT NewswiresApr 23 02:12 ET